Objective To estimate the prevalence of neuropsychiatric disorders, including autism
spectrum disorders (ASDs), attention-deficit hyperactivity disorder (ADHD), depression …

Patients with Duchenne muscular dystrophy (DMD) show clinically relevant phenotypic
variability, despite sharing the same primary biochemical defect (dystrophin deficiency) …

Although regulatory agencies encourage inclusion of imaging biomarkers in clinical trials for
Duchenne muscular dystrophy (DMD), industry receives minimal guidance on how to use …

Aim To estimate the global prevalence of intellectual developmental disorder (IDD) and the
IDD prevalence–genotype association in Becker muscular dystrophy (BMD) or Duchenne …

Duchenne muscular dystrophy (DMD) is a fatal X‐linked disease that leads to premature
death due to the loss of dystrophin. Current strategies predominantly focus on the …

Dystrophin alterations in the brain have been associated with an increased risk of epilepsy
in Becker and Duchenne muscular dystrophies (BMD and DMD). Moreover, an association …

Genetic modifiers of Duchenne muscular dystrophy (DMD) are variants located in genes
different from the disease-causing gene DMD, but associated with differences in disease …

Aims Becker muscular dystrophy (BMD) and Duchenne muscular dystrophy (DMD) are
associated with intelligence quotients (IQs) lower than the normative values, and it is …

The Dystrophinopathies : CONTINUUM: Lifelong Learning in Neurology Account Register
Activate Subscription Help Subscribe American Academy of Neurology Login Journal logo …

Background: Dystrophinopathies are associated with neuropsychiatric disorders due to
alterations in dystrophin/DMD expression. Objective: The objective was to estimate the …